Dr. Couvillon attended Colby College in Waterville, Maine (USA) where he majored in Biology and Chemistry. Post-graduation, he became a research associate in the laboratories of Dr. Christopher L. Carpenter and Lewis Cantley at the Harvard Medical School where he was introduced to the fascinating world of signal transduction, lipid kinases and the role of Ras-like proteins in disease. Under the tutelage of Dr. John H. Exton at Vanderbilt University (Nashville, Tennessee), Dr. Couvillon received his Ph.D. in Molecular Physiology and Biophysics while studying the role of Rho-family proteins and their regulators in neuronal function. He then returned to Harvard and Beth-Israel Deaconess Medical Center where he rejoined the Cantley lab to continue his work on Rho-family GTPases and their role in immune cell development and function, neuronal plasticity and cardiac development. Dr. Couvillon joined Cell Signaling Technology in 2009 as a Development Scientist, developing and validating antibody products in the MAPK, lipid signaling and other pathways. He has also worked extensively in the proteomics space, developing novel antibody reagents against novel post-translational modification and reagents that detect specific substrate motifs for high-throughput proteomics analysis. Dr. Couvillon currently works as a Scientific Project Manager focused on initiatives promoting antibody reproducibility in research.